Day: April 6, 2022

BUTTE, Mont. and SIOUX FALLS, S.D., April 06, 2022 (GLOBE NEWSWIRE) — NorthWestern Corporation d/b/a NorthWestern Energy (Nasdaq: NWE) today announced that it will host an investor webinar on Friday, April 29, 2022, at 2:30 p.m. Eastern Daylight Time to review its financial results for the quarter ending March 31, 2022. The Company also plans to issue a news release detailing its first quarter financial results the evening of April 28, 2022, after stock market close. To register for the webinar, please visit www.northwesternenergy.com/earnings-registration. Please go to the site at least 10 minutes in advance of the webinar to register. An archived webcast will be available shortly after the event and remain active for one year.        Notice of Virtual Annual Stockholders MeetingThe virtual Annual Stockholders Meeting will be...

WATERTOWN, Mass., April 06, 2022 (GLOBE NEWSWIRE) — Selecta Biosciences, Inc. (Nasdaq: SELB) (“Selecta” or the “Company”), a biotechnology company focused on developing tolerogenic therapies to mitigate unwanted immune responses, today announced that it has agreed to sell 27,428,572 shares of its common stock and accompanying warrants to purchase up to 20,571,429 shares of common stock at a combined offering price of $1.41 per share and accompanying warrant. The warrants to purchase shares of common stock have an exercise price of $1.55 per share, are immediately exercisable and will expire five years from the date of issuance. All of the securities in the offering will be sold by Selecta. The gross proceeds to Selecta from the offering, before deducting underwriting discounts and commissions and other offering expenses, are expected...

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, April 06, 2022 (GLOBE NEWSWIRE) — RioCan Real Estate Investment Trust (“RioCan” or the “Trust”) (TSX: REI.UN) today announced that it has agreed to issue $250 million principal amount of Series AF senior unsecured debentures (the “Debentures”). This issuance provides additional liquidity to RioCan to support its strategy, pursue opportunities and manage potential risks. Inclusive of the benefit of bond forward hedges, the all-in rate of 3.829% is favourable compared to current market rates and RioCan has an additional $250 million of bond forward contracts in place to hedge future issuances. The Debentures will be sold at a price of $99.998 per $100 principal amount, with a coupon rate of 4.628% per annum and mature on May 1, 2029. To hedge...

WICHITA, Kan., April 06, 2022 (GLOBE NEWSWIRE) — Equity Bancshares, Inc. (NASDAQ:EQBK), (“Equity”), the Wichita-based holding company of Equity Bank, will release its first quarter results on Tuesday, April 19, 2022, with a press release issued after market close. Equity Chairman and Chief Executive Officer Brad Elliott and Chief Financial Officer Eric Newell will hold a conference call and webcast to discuss first quarter results on Wednesday, April 20, 2022 at 10 a.m. eastern time or 9 a.m. central time. Investors, news media, and other participants may dial into the call toll-free at (844) 534-7311 from anywhere in the U.S. or (574) 990-1419 internationally, using conference ID no. 1392188. Presentation slides to pair with the call will be posted one hour prior to the call at investor.equitybank.com. Alternatively, participants...

Vancouver, BC, April 06, 2022 (GLOBE NEWSWIRE) — Rockridge Resources Ltd. (TSX-V: ROCK) (OTCQB: RRRLF) (Frankfurt: RR0) (“Rockridge” or the “Company”) announces that the Company has granted 2,100,000 incentive stock options (the “Options”) to officers, directors and consultants of the Company. The Options are exercisable at $0.10 per share for a period of five years from the date of grant. The Options have been granted under and are governed by the terms of the Company’s Incentive Stock Option Plan. About Rockridge Resources Ltd. Rockridge Resources (TSX.V: ROCK) is a public mineral exploration company focused on the acquisition, exploration and development of mineral resource properties in Canada, specifically copper and gold. The Company’s core copper project is the Knife Lake Project located in Saskatchewan...

SB 1469 (Bradford & Becker): Granting Water Utility Decoupling Makes It Easier to Achieve Significant Water Conservation SAN JOSE, Calif., April 06, 2022 (GLOBE NEWSWIRE) — California Water Service (Cal Water), the largest water utility regulated by the California Public Utilities Commission, released a new study today demonstrating that its water conservation efforts from 2008 to 2019 significantly lowered water use, which decreased operating costs and in turn reduced customer bills by as much as 20 percent from what they would have been without the conservation efforts. Water conservation has been shown time and again to be the lowest-cost source of supply, because when less water is used, costly investments required to produce additional water supplies can be deferred and potentially avoided. This study, “The Economic Value...

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, April 06, 2022 (GLOBE NEWSWIRE) — FIREWEED ZINC LTD. (“Fireweed” or the “Company”) (TSXV: FWZ; OTCQB: FWEDF; FSE: 20F) is pleased to announce that it has closed the first tranche of the previously announced non-brokered private placement (the “Offering”). This tranche consists of 5,586,444 Common Shares at a price of CAD$0.70 per share and 7,200,000 flow-through common shares at a price of CAD$0.99 per share (“Flow-Through Shares”) for total proceeds of $11,038,511. Remaining orders will be closed once all necessary subscription agreements and filings are complete. The proceeds from the Offering will be used for exploration and development of the Company’s Macmillan Pass Project in Yukon, Canada, and for...

CAMBRIDGE, Mass., April 06, 2022 (GLOBE NEWSWIRE) — Spero Therapeutics, Inc. (Nasdaq: SPRO) today announced publication in The New England Journal of Medicine (NEJM) of the results from the Phase 3 ADAPT-PO clinical trial for its investigational oral carbapenem antibiotic, tebipenem pivoxil hydrobromide (tebipenem HBr). The paper, titled “Oral Tebipenem Pivoxil Hydrobromide in Complicated Urinary Tract Infection,” is available online at the New England Journal of Medicine (NEJM). “ADAPT-PO was a landmark trial that is the first Phase 3 head-to-head comparison of an all-oral versus all-IV treatment regimen in complicated urinary tract infection (cUTI) or acute pyelonephritis,” said Angela Talley, M.D., Senior Vice President, Clinical Development at Spero Therapeutics, and senior author of the NEJM paper. “We are honored to have...